245 related articles for article (PubMed ID: 18696151)
1. FDG-MicroPET and diffusion-weighted MR image evaluation of early changes after radiofrequency ablation in implanted VX2 tumors in rabbits.
Ohira T; Okuma T; Matsuoka T; Wada Y; Nakamura K; Watanabe Y; Inoue Y
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):114-20. PubMed ID: 18696151
[TBL] [Abstract][Full Text] [Related]
2. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits.
Okuma T; Matsuoka T; Okamura T; Wada Y; Yamamoto A; Oyama Y; Koyama K; Nakamura K; Watanabe Y; Inoue Y
J Nucl Med; 2006 Aug; 47(8):1351-8. PubMed ID: 16883016
[TBL] [Abstract][Full Text] [Related]
3. Diffusion-weighted magnetic resonance imaging to evaluate microvascular density after transarterial embolization ablation in a rabbit VX2 liver tumor model.
Qian T; Chen M; Gao F; Meng F; Gao X; Yin H
Magn Reson Imaging; 2014 Oct; 32(8):1052-7. PubMed ID: 24970024
[TBL] [Abstract][Full Text] [Related]
4. Intravoxel Incoherent Motion Diffusion-weighted MR Imaging for Early Evaluation of the Effect of Radiofrequency Ablation in Rabbit Liver VX2 Tumors.
Shanshan L; Feng S; Kaikai W; Yijun Z; Huiming L; Chuanmiao X
Acad Radiol; 2018 Sep; 25(9):1128-1135. PubMed ID: 29478919
[TBL] [Abstract][Full Text] [Related]
5. 2-[Fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience.
Komori T; Narabayashi I; Matsumura K; Matsuki M; Akagi H; Ogura Y; Aga F; Adachi I
Ann Nucl Med; 2007 Jun; 21(4):209-15. PubMed ID: 17581719
[TBL] [Abstract][Full Text] [Related]
6. Intravoxel Incoherent Motion Diffusion Weighted MR Imaging for Monitoring the Instantly Therapeutic Efficacy of Radiofrequency Ablation in Rabbit VX2 Tumors without Evident Links between Conventional Perfusion Weighted Images.
Guo Z; Zhang Q; Li X; Jing Z
PLoS One; 2015; 10(5):e0127964. PubMed ID: 26020785
[TBL] [Abstract][Full Text] [Related]
7. Initial experience in small animal tumor imaging with a clinical positron emission tomography/computed tomography scanner using 2-[F-18]fluoro-2-deoxy-D-glucose.
Tatsumi M; Nakamoto Y; Traughber B; Marshall LT; Geschwind JF; Wahl RL
Cancer Res; 2003 Oct; 63(19):6252-7. PubMed ID: 14559811
[TBL] [Abstract][Full Text] [Related]
8. A Population-Based Gaussian Mixture Model Incorporating 18F-FDG PET and Diffusion-Weighted MRI Quantifies Tumor Tissue Classes.
Divine MR; Katiyar P; Kohlhofer U; Quintanilla-Martinez L; Pichler BJ; Disselhorst JA
J Nucl Med; 2016 Mar; 57(3):473-9. PubMed ID: 26659350
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic response to radiofrequency ablation of neoplastic lesions: FDG PET/CT findings.
Purandare NC; Rangarajan V; Shah SA; Sharma AR; Kulkarni SS; Kulkarni AV; Dua SG
Radiographics; 2011; 31(1):201-13. PubMed ID: 21257942
[TBL] [Abstract][Full Text] [Related]
10. Ionising radiation-free whole-body MRI versus (18)F-fluorodeoxyglucose PET/CT scans for children and young adults with cancer: a prospective, non-randomised, single-centre study.
Klenk C; Gawande R; Uslu L; Khurana A; Qiu D; Quon A; Donig J; Rosenberg J; Luna-Fineman S; Moseley M; Daldrup-Link HE
Lancet Oncol; 2014 Mar; 15(3):275-85. PubMed ID: 24559803
[TBL] [Abstract][Full Text] [Related]
11. Value of
Kan X; Ren Y; Li X; Kong X; Zhang Y; Li Q; Liu F; Zhang Y; Zheng C
J Vasc Interv Radiol; 2022 Apr; 33(4):452-459.e3. PubMed ID: 34607002
[TBL] [Abstract][Full Text] [Related]
12. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
[TBL] [Abstract][Full Text] [Related]
13. Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume corrected standardized uptake value with histological tumor regression grade.
Giganti F; De Cobelli F; Canevari C; Orsenigo E; Gallivanone F; Esposito A; Castiglioni I; Ambrosi A; Albarello L; Mazza E; Gianolli L; Staudacher C; Del Maschio A
J Magn Reson Imaging; 2014 Nov; 40(5):1147-57. PubMed ID: 24214734
[TBL] [Abstract][Full Text] [Related]
14. Morphologic and functional changes in nontumorous liver tissue after radiofrequency ablation in an in vivo model: comparison of 18F-FDG PET/CT, MRI, ultrasound, and CT.
Vogt FM; Antoch G; Veit P; Freudenberg LS; Blechschmid N; Diersch O; Bockisch A; Barkhausen J; Kuehl H
J Nucl Med; 2007 Nov; 48(11):1836-44. PubMed ID: 17942811
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology.
Oyama Y; Nakamura K; Matsuoka T; Toyoshima M; Yamamoto A; Okuma T; Ikura Y; Ueda M; Inoue Y
Cardiovasc Intervent Radiol; 2005; 28(3):346-53. PubMed ID: 15886942
[TBL] [Abstract][Full Text] [Related]
16. Whole-body diffusion-weighted MRI and (18)F-FDG PET/CT can discriminate between different lymphoma subtypes.
Mosavi F; Wassberg C; Selling J; Molin D; Ahlström H
Clin Radiol; 2015 Nov; 70(11):1229-36. PubMed ID: 26208992
[TBL] [Abstract][Full Text] [Related]
17. MR diffusion weighted imaging for evaluation of radiotherapeutic effects on rabbit VX2 tumor model.
Li S; Xue HD; Wang XH; Sun F; Jiang B; Liu D; Lei J; Jin ZY
Chin Med Sci J; 2008 Sep; 23(3):172-7. PubMed ID: 18853853
[TBL] [Abstract][Full Text] [Related]
18. Measurement of apparent diffusion coefficient with simultaneous MR/positron emission tomography in patients with peritoneal carcinomatosis: comparison with 18F-FDG-PET.
Schwenzer NF; Schmidt H; Gatidis S; Brendle C; Müller M; Königsrainer I; Claussen CD; Pfannenberg AC; Schraml C
J Magn Reson Imaging; 2014 Nov; 40(5):1121-8. PubMed ID: 24923481
[TBL] [Abstract][Full Text] [Related]
19. Hybrid [¹⁸F]-FDG PET/MRI including non-Gaussian diffusion-weighted imaging (DWI): preliminary results in non-small cell lung cancer (NSCLC).
Heusch P; Köhler J; Wittsack HJ; Heusner TA; Buchbender C; Poeppel TD; Nensa F; Wetter A; Gauler T; Hartung V; Lanzman RS
Eur J Radiol; 2013 Nov; 82(11):2055-60. PubMed ID: 23830904
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory myofibroblastic tumours of the liver: gadoxetic acid-enhanced and diffusion-weighted MRI findings with 18F-FDG PET/CT and clinical significance of regression on follow-up.
Kang TW; Kim SH; Jang KM; Choi D; Choi JY; Park CK
Clin Radiol; 2014 May; 69(5):509-18. PubMed ID: 24581965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]